Document:

EX-10.19

 Exhibit 10.19 

AKILI INTERACTIVE LABS, INC. 

AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN 

1.    Purpose 
 The
purpose of this Amended and Restated 2011 Stock Incentive Plan (the “Plan”) of Akili Interactive Labs, Inc., a Delaware corporation (the “Company”), is to advance the interests of the Company’s stockholders by
enhancing the Company’s ability to attract, retain and motivate persons who are expected to make important contributions to the Company and by providing such persons with equity ownership opportunities and performance-based incentives to better
align the interests of such persons with those of the Company’s stockholders. Except where the context otherwise requires, the term “Company” shall include any of the Company’s present or future parent or subsidiary corporations
as defined in Sections 424(e) or (f) of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”) and any other business venture (including, without limitation, joint venture or
limited liability company) in which the Company has a controlling interest, as determined by the Board of Directors of the Company (the “Board”). 

2.    Eligibility 

All of the Company’s employees, officers, directors, consultants and advisors who are selected from time to time by the Board and who meet
the requirements of Rule 701(c) of the Securities Act of 1933, as amended, are eligible to be granted non-qualified stock options, incentive stock options restricted stock, restricted stock units and other
stock-based awards (each, an “Award”) under the Plan. Each person who receives an Award under the Plan is deemed a “Participant”. 

3.    Administration and Delegation 

(a)    Administration by Board of Directors. The Plan will be administered by the Board. The Board shall have
authority to select individuals to whom Awards may from time to time be granted, to grant Awards and determine and, subject to the provisions of the Plan, to modify from time to time the terms and conditions, including restrictions, not inconsistent
with the Plan, of any Award, which terms and conditions may differ among individual Awards and Participants, and to approve the form of written instruments evidencing the Awards. The Board may adopt, amend and repeal such administrative rules,
guidelines and practices for the administration of the Plan and for its own acts and proceedings as it shall deem advisable. The Board may construe and interpret the terms of the Plan and any Award agreements entered into under the Plan. The Board
may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem expedient to carry the Plan into effect and it shall be the sole and final judge of such expediency.
All decisions by the Board shall be made in the Board’s sole discretion and shall be final and binding on all persons having or claiming any interest in the Plan or in any Award. No director or person acting pursuant to the authority delegated
by the Board shall be liable for any action or determination relating to or under the Plan made in good faith. 

 (b)    Appointment of Committees. To the extent permitted by
applicable law, the Board may delegate any or all of its powers under the Plan to one or more committees or subcommittees of the Board (a “Committee”). All references in the Plan to the “Board” shall mean the Board or a
Committee of the Board or the officers referred to in Section 3(c) to the extent that the Board’s powers or authority under the Plan have been delegated to such Committee or officers. 

(c)    Delegation to Officers. To the extent permitted by applicable law, the Board may delegate to one or more
officers of the Company the power to grant Awards (subject to any limitations under the Plan) to employees or officers of the Company or any of its present or future subsidiary corporations and to exercise such other powers under the Plan as the
Board may determine, provided that the Board shall fix the terms of the Awards to be granted by such officers (including the exercise price of such Awards, which may include a formula by which the exercise price will be determined) and the maximum
number of shares subject to Awards that the officers may grant; provided further, however, that no officer shall be authorized to grant Awards to any “executive officer” of the Company (as defined by Rule
3b-7 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) or to any “officer” of the Company (as defined by Rule 16a-1 under
the Exchange Act). 
 4.    Stock Available for Awards. 

(a)    Number of Shares. Subject to adjustment under Section 8, Awards may be made under the Plan for up
to 11,737,602 shares of common stock, $0.0001 par value per share, of the Company (the “Common Stock”). If any Award expires or is terminated, surrendered or canceled without having been fully exercised, is forfeited in whole or in
part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the original issuance price pursuant to a contractual repurchase right), or results in any Common Stock not being issued, the unused
shares of Common Stock covered by such Award shall again be available for the grant of Awards under the Plan. Further, shares of Common Stock tendered to the Company by a Participant to exercise an Award shall be added to the number of shares of
Common Stock available for the grant of Awards under the Plan. However, in the case of Incentive Stock Options (as hereinafter defined), the foregoing provisions shall be subject to any limitations under the Code. Shares issued under the Plan may
consist in whole or in part of authorized but unissued shares or treasury shares. 
 (b)    Substitute Awards. In
connection with a merger or consolidation of an entity with the Company or the acquisition by the Company of property or stock of an entity, the Board may grant Awards in substitution for any options or other stock or stock-based awards granted by
such entity or an affiliate thereof. Substitute Awards may be granted on such terms as the Board deems appropriate in the circumstances, notwithstanding any limitations on Awards contained in the Plan. Substitute Awards shall not count against the
overall share limit set forth in Section 4(a), except as may be required by reason of Section 422 and related provisions of the Code. 

5.    Stock Options 

(a)    General. The Board may grant options to purchase Common Stock (each, an “Option”) and
determine the number of shares of Common Stock to be covered by each Option, 

  
 2 

 
the exercise price of each Option and the conditions and limitations applicable to the exercise of each Option, including conditions relating to applicable laws, including federal or state
securities laws, as it considers necessary or advisable. An Option that is not intended to be an Incentive Stock Option shall be designated a “Nonstatutory Stock Option”. 

(b)    Incentive Stock Options. An Option that the Board intends to be an “incentive stock option” as
defined in Section 422 of the Code (an “Incentive Stock Option”) shall only be granted to employees of the Company, any of the Company’s present or future parent or subsidiary corporations as defined in Sections
424(e) or (f) of the Code, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code, and shall be subject to and shall be construed consistently with the requirements of
Section 422 of the Code. The Company shall have no liability to a Participant, or any other party, if an Option (or any part thereof) that is intended to be an Incentive Stock Option is not an Incentive Stock Option or for any action
taken by the Board, including without limitation the conversion of an Incentive Stock Option to a Nonstatutory Stock Option. To the extent required for “incentive stock option” treatment under Section 422 of the Code, the
aggregate Fair Market Value (as defined below and determined as of the time of grant) of the shares of Common Stock with respect to which Incentive Stock Options granted under the Plan and any other plan of the Company or its parent and any
subsidiary that become exercisable for the first time by a Participant during any calendar year shall not exceed $100,000 or such other limit as may be in effect from time to time under Section 422 of the Code. To the extent that any
Stock Option exceeds this limit, it shall constitute a Nonstatutory Stock Option. 
 (c)    Exercise Price. The
Board shall establish the exercise price of each Option and specify the exercise price in the applicable option agreement. The exercise price shall be not less than 100% of the Fair Market Value (as defined below) on the date the Option is granted.
In the case of an Incentive Stock Option that is granted to an employee who owns or is deemed to own more than 10% of the combined voting power of all classes of stock of the Company or any of its parent or subsidiaries (a “Ten Percent
Owner”), the exercise price of such Incentive Stock Option shall be not less than 110% of the Fair Market Value on the date the Incentive Stock Option is granted. 

(d)    Duration of Options. Each Option shall be exercisable at such times and subject to such terms and conditions
as the Board may specify in the applicable option agreement, but no Stock Option shall be exercisable more than ten years after the date the Option is granted. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the term
of such Option shall be no more than five years. 
 (e)    Exercise of Options. Options may be exercised by
delivery to the Company of a written notice of exercise signed by the proper person or by any other form of notice (including electronic notice) approved by the Board together with payment in full as specified in Section 5(f) for the
number of shares for which the Option is exercised. Shares of Common Stock subject to the Option will be delivered by the Company as soon as practicable following exercise. 

  
 3 

 (f)    Payment Upon Exercise. Common Stock purchased upon the
exercise of an Option granted under the Plan shall be paid for as follows: 
 (1)    in cash, by certified or bank
check, by wire transfer of immediately available funds, or other instrument acceptable to the Board; 
 (2)    if the
Common Stock is registered under the Exchange Act, except as may otherwise be provided in the applicable Option agreement, by (i) delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the
Company sufficient funds to pay the exercise price and any required tax withholding or (ii) delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the
Company cash or a check sufficient to pay the exercise price and any required tax withholding; 
 (3)    if the Common
Stock is registered under the Exchange Act and to the extent provided for in the applicable Option agreement or approved by the Board, in its sole discretion, by delivery (either by actual delivery or attestation) of shares of Common Stock owned by
the Participant valued at their fair market value as determined by (or in a manner approved by) the Board (“Fair Market Value”), provided (i) such method of payment is then permitted under applicable law, (ii) such shares
of Common Stock, if acquired directly from the Company, were owned by the Participant for such minimum period of time, if any, as may be established by the Board in its discretion and (iii) such shares of Common Stock are not subject to any
repurchase, forfeiture, unfulfilled vesting or other similar requirements; 
 (4)    If permitted by the Board with
respect to Options that are not Incentive Stock Options, by a “net exercise” arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a
Fair Market Value that does not exceed the aggregate exercise price; 
 (5)    to the extent permitted by applicable
law and provided for in the applicable option agreement or approved by the Board, in its sole discretion, by (i) delivery of a promissory note of the Participant to the Company on terms determined by the Board, or (ii) payment of such
other lawful consideration as the Board may determine; or 
 (6)    by any combination of the above permitted forms of
payment. 
 6.    Restricted Stock; Restricted Stock Units 

(a)    General. The Board may grant Awards entitling recipients to acquire shares of Common Stock
(“Restricted Stock”), subject to the right of the Company to repurchase all or part of such shares at their issue price or other stated or formula price (or to require forfeiture of such shares if issued at no cost) from the
recipient in the event that conditions specified by the Board in the applicable Award are not satisfied prior to the end of the applicable restriction period or periods established by the Board for such Award. The Board may also grant Awards
entitling the recipient to receive an award of stock units to a Participant, which may be settled in cash or shares of Common Stock at the time such Award vests (“Restricted Stock Units”) (Restricted Stock and Restricted Stock Units
are each referred to herein as a “Restricted Stock Award”). 

  
 4 

 (b)    Terms and Conditions for All Restricted Stock Awards. The
Board shall determine the terms and conditions of a Restricted Stock Award, including the conditions for vesting and repurchase (or forfeiture) and the issue price, if any. 

(c)    Additional Provisions Relating to Restricted Stock. 

(1)    Dividends. Participants holding shares of Restricted Stock will be entitled to all ordinary cash dividends
paid with respect to such shares, unless otherwise provided by the Board. Unless otherwise provided by the Board, if any dividends or distributions are paid in shares, or consist of a dividend or distribution to holders of Common Stock other than an
ordinary cash dividend, the shares, cash or other property will be subject to the same restrictions on transferability and forfeitability as the shares of Restricted Stock with respect to which they were paid. Each dividend payment will be made no
later than the end of the calendar year in which the dividends are paid to shareholders of that class of stock or, if later, the 15th day of the third month following the date the dividends are paid to shareholders of that class of stock. 

(2)    Stock Certificates. The Company may require that any stock certificates issued in respect of shares of
Restricted Stock shall be deposited in escrow by the Participant, together with a stock power endorsed in blank, with the Company (or its designee). At the expiration of the applicable restriction periods, the Company (or such designee) shall
deliver the certificates no longer subject to such restrictions to the Participant or if the Participant has died, to the beneficiary designated, in a manner determined by the Board, by a Participant to receive amounts due or exercise rights of the
Participant in the event of the Participant’s death (the “Designated Beneficiary”). In the absence of an effective designation by a Participant, “Designated Beneficiary” shall mean the Participant’s estate. 

7.    Other Stock-Based Awards 

Other Awards of shares of Common Stock, and other Awards that are valued in whole or in part by reference to, or are otherwise based on, shares
of Common Stock or other property, may be granted hereunder to Participants (“Other Stock-Based Awards”), including without limitation stock appreciation rights (“SARs”) and Awards entitling recipients to receive
shares of Common Stock to be delivered in the future. Such Other Stock-Based Awards shall also be available as a form of payment in the settlement of other Awards granted under the Plan or as payment in lieu of compensation to which a Participant is
otherwise entitled. Other Stock-Based Awards may be paid in shares of Common Stock or cash, as the Board shall determine. Subject to the provisions of the Plan, the Board shall determine the terms and conditions of each Other Stock-Based Award,
including any purchase price applicable thereto. 
 8.    Adjustments for Changes in Common Stock and Certain Other Events 

(a)    Changes in Capitalization. In the event of any stock split, reverse stock split, stock dividend,
recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of Common Stock other than an
ordinary cash dividend, (i) the number and class of securities available under this Plan, (ii) the number and class of securities and exercise price per share of each outstanding Option, (iii) the number of shares subject to and the
repurchase price per share 

  
 5 

 
subject to each outstanding Restricted Stock Award, and (iv) the terms of each other outstanding Award shall be equitably adjusted by the Company (or substituted Awards may be made, if
applicable) in the manner determined by the Board. Without limiting the generality of the foregoing, in the event the Company effects a split of the Common Stock by means of a stock dividend and the exercise price of and the number of shares subject
to an outstanding Option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then an optionee who exercises an Option between the record date and the distribution date for such stock
dividend shall be entitled to receive, on the distribution date, the stock dividend with respect to the shares of Common Stock acquired upon such Option exercise, notwithstanding the fact that such shares were not outstanding as of the close of
business on the record date for such stock dividend. 
 (b)    Reorganization Events. 

(1)    Definition. A “Reorganization Event” shall mean: (i) the dissolution or liquidation of the
Company, (ii) the sale of all or substantially all of the assets of the Company on a consolidated basis to an unrelated person or entity, (iii) a merger, reorganization or consolidation pursuant to which the holders of the Company’s
outstanding voting power immediately prior to such transaction do not own a majority of the outstanding voting power of the surviving or resulting entity (or its ultimate parent, if applicable), (iv) the acquisition of all or a majority of the
outstanding voting stock of the Company in a single transaction or a series of related transactions by a person or group of persons, or (v) any other merger, acquisition, reorganization, consolidation, combination or reclassification of the
Company, as determined by the Board; provided, however, that the Company’s first firm commitment underwritten public offering of its Common Stock under the Securities Act of 1933, as amended, any subsequent public
offering or another capital raising event, or a merger effected solely to change the Company’s domicile shall not constitute a “Reorganization Event”. 

(2)    Consequences of a Reorganization Event on Awards Other than Restricted Stock Awards. In connection with a
Reorganization Event, the Board may take any one or more of the following actions as to all or any (or any portion of) outstanding Awards other than Restricted Stock Awards on such terms as the Board determines: (i) provide that Awards shall be
assumed, or substantially equivalent Awards shall be substituted with new awards, by the acquiring or succeeding corporation (or an affiliate thereof), (ii) provide that the Participant’s unexercised Awards will terminate immediately prior to
the consummation of such Reorganization Event unless exercised by the Participant within a specified period determined by the Board, (iii) provide that outstanding Awards shall become exercisable, realizable, or deliverable, or restrictions
applicable to an Award shall lapse, in whole or in part prior to or upon such Reorganization Event, (iv) in the event of a Reorganization Event under the terms of which holders of Common Stock will receive upon consummation thereof a cash
payment for each share surrendered in the Reorganization Event in such amount as determined by the Board (the “Acquisition Price”), make or provide for a cash payment to a Participant equal to the excess, if any, of (A) the
Acquisition Price times the number of shares of Common Stock subject to the vested portion of a Participant’s Awards (to the extent the exercise price does not exceed the Acquisition Price) over (B) the aggregate exercise price of all such
outstanding Awards and any applicable tax withholdings, in exchange for the termination of such Awards, (v) provide that, in connection with a liquidation or dissolution of the Company, Awards shall convert into the right

  
 6 

 
to receive liquidation proceeds (if applicable, net of the exercise price thereof and any applicable tax withholdings) and (vi) any combination of the foregoing. In taking any of the actions
permitted under this Section 8(b), the Board shall not be obligated by the Plan to treat all Awards, all Awards held by a Participant, or all Awards of the same type, identically. 

For purposes of clause (i) above, an Option shall be considered assumed if, following consummation of the Reorganization Event, the
Option confers the right to purchase, for each share of Common Stock subject to the Option immediately prior to the consummation of the Reorganization Event, the consideration (whether cash, securities or other property) received as a result of the
Reorganization Event by holders of Common Stock for each share of Common Stock held immediately prior to the consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration chosen by the
holders of a majority of the outstanding shares of Common Stock); provided, however, that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate
thereof), the Company may, with the consent of the acquiring or succeeding corporation, provide for the consideration to be received upon the exercise of Options to consist solely of common stock of the acquiring or succeeding corporation (or an
affiliate thereof) equivalent in value (as determined by the Board) to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Reorganization Event. 

(3)    Consequences of a Reorganization Event on Restricted Stock Awards. Upon the occurrence of a Reorganization
Event other than a liquidation or dissolution of the Company, the Board may take any one or more of the following actions as to all or any (or any portion of) outstanding Restricted Stock Awards on such terms as the Board determines (i) provide
that such Restricted Stock Awards shall be assumed, continued or substituted by the acquiror and the repurchase and other rights of the Company under each outstanding Restricted Stock Award shall inure to the benefit of the Company’s successor
and shall, unless the Board determines otherwise, apply to the cash, securities or other property which the Common Stock was converted into or exchanged for pursuant to such Reorganization Event in the same manner and to the same extent as they
applied to the Common Stock subject to such Restricted Stock Award, (ii) provide that any Restricted Stock Awards shall be forfeited immediately prior to the effective time of any such Reorganization Event and any such Restricted Stock so
forfeited shall be repurchased from the Participant at a price per share equal to the original per share purchase price paid by the Participant (subject to adjustment as provided herein) for such Shares; (iii) notwithstanding anything to the
contrary set forth herein, the Company shall have the right, but not the obligation, to make or provide for a cash payment to the Participants who hold Restricted Stock Awards, without consent of such Participants, in exchange for the cancellation
thereof, in an amount equal to the Acquisition Price times the number of Shares subject to such Awards, to be paid at the time of such Reorganization Event or upon the later vesting of such Awards; and (iv) any combination of the foregoing. In
taking any of the actions permitted under this Section 8(b), the Board shall not be obligated by the Plan to treat all Awards, all Awards held by a Participant, or all Awards of the same type, identically. 

Upon the occurrence of a Reorganization Event involving the liquidation or dissolution of the Company, except to the extent specifically
provided to the contrary in the instrument evidencing any Restricted Stock Award or any other agreement between a Participant and the Company, all restrictions and conditions on all Restricted Stock Awards then outstanding shall automatically be
deemed terminated or satisfied. 

  
 7 

 9.    General Provisions Applicable to Awards 

(a)    Transferability of Awards. Except as the Board may otherwise determine or provide in an Award Agreement (as
defined below), Awards shall not be sold, assigned, transferred, pledged or otherwise encumbered by the person to whom they are granted, either voluntarily or by operation of law, except by will or the laws of descent and distribution or, other than
in the case of an Incentive Stock Option, pursuant to a qualified domestic relations order, and, during the life of the Participant, shall be exercisable only by the Participant. References to a Participant, to the extent relevant in the context,
shall include references to authorized transferees. 
 (b)    Documentation. Each Award shall be evidenced in
such form (written, electronic or otherwise) as the Board shall determine (each an “Award Agreement”). Each Award Agreement may contain terms and conditions in addition to those set forth in the Plan, which may include, without
limitation, the provisions applicable in the event employment or service terminates, and the Company’s authority to unilaterally or bilaterally amend, modify, suspend, cancel or rescind an Award. 

(c)    Lock-Up. If requested by the Company, a Participant shall not sell
or otherwise transfer or dispose of any Shares (including, without limitation, pursuant to Rule 144 under the Securities Act of 1933, as amended) held by him or her for such period following the effective date of a public offering by the Company of
Shares as the Company shall specify reasonably and in good faith. If requested by the underwriter engaged by the Company, each Participant shall execute a separate letter confirming his or her agreement to comply with this Section. 

(d)    Board Discretion. Except as otherwise provided by the Plan, each Award may be made alone or in addition or
in relation to any other Award. The terms of each Award need not be identical, and the Board need not treat Participants uniformly. 

(e)    Termination of Status. The Board shall determine the effect on an Award of the disability, death,
termination or other cessation of employment or service, authorized leave of absence or other change in the employment or service or other status of a Participant and the extent to which, and the period during which, the Participant, or the
Participant’s legal representative, conservator, guardian or Designated Beneficiary, may exercise rights under the Award. 

(f)    Withholding. The Participant must satisfy all applicable federal, state, and local or other income and
employment tax withholding obligations before the Company will deliver stock certificates or otherwise recognize ownership of Common Stock or make any cash payment under an Award. The Company may decide to satisfy the withholding obligations through
additional withholding on salary or wages. If the Company elects not to or cannot withhold from other compensation, the Participant must pay the Company the full amount, if any, required for withholding or have a broker tender to the Company cash
equal to the withholding obligations. Payment of withholding obligations is due before the Company will 

  
 8 

 
issue any shares on exercise, release from forfeiture, or settlement of an Award or, if the Company so requires, at the same time as payment of the exercise price unless the Company determines
otherwise. If provided for in an Award or approved by the Board in its sole discretion, a Participant may satisfy such tax obligations in whole or in part by delivery of shares of Common Stock, including shares retained from the Award creating the
tax obligation, valued at their Fair Market Value; provided, however, except as otherwise provided by the Board, that the total tax withholding where stock is being used to satisfy such tax obligations cannot exceed the Company’s statutory
withholding obligations (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable income). Such tax withholding may also be satisfied by the Company
causing its transfer agent to sell a number of Shares with an aggregate Fair Market Value (as of the date the withholding is effected) that would satisfy the withholding amount due and remitting the proceeds from such sale to the Company. Shares
surrendered to satisfy tax withholding requirements cannot be subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements. 

(g)    Amendment of Award. 

(1)    The Board may amend, modify or terminate any outstanding Award, including but not limited to, substituting
therefor another Award of the same or a different type, changing the date of exercise or realization, and converting an Incentive Stock Option to a Nonstatutory Stock Option. The Participant’s consent to such action shall be required unless
(i) the Board determines that the action, taking into account any related action, would not materially and adversely affect the Participant’s rights under the Plan or (ii) the change is permitted under Section 8 hereof. 

(2)    The Board may, without stockholder approval, amend any outstanding Award granted under the Plan to provide an
exercise price per share that is lower than the then-current exercise price per share of such outstanding Award. The Board may also, without stockholder approval, cancel any outstanding award (whether or not granted under the Plan) and grant in
substitution therefor new Awards under the Plan covering the same or a different number of shares of Common Stock and having an exercise price per share lower than the then-current exercise price per share of the cancelled award; provided, that such
price, if any, must satisfy the requirements that would apply to the substituted or amended award if it were then initially granted under the Plan for purpose of satisfying changes in law or for any other lawful purpose). 

(h)    Conditions on Delivery of Stock. The Company will not be obligated to deliver any shares of Common Stock
pursuant to the Plan or to remove restrictions from shares previously delivered under the Plan until (i) all conditions of the Award have been met or removed to the satisfaction of the Company, (ii) in the opinion of the Company’s
counsel, all other legal matters in connection with the issuance and delivery of such shares have been satisfied, including any applicable securities laws and any applicable stock exchange or stock market rules and regulations, and (iii) the
Participant has executed and delivered to the Company such representations or agreements as the Company may consider appropriate to satisfy the requirements of any applicable laws, rules or regulations. 

  
 9 

 (i)    Acceleration. The Board may at any time provide that any
Award shall become immediately exercisable in full or in part, free of some or all restrictions or conditions, or otherwise realizable in full or in part, as the case may be. 

10.    Miscellaneous 

(a)    No Right To Employment or Other Status. No person shall have any claim or right to be granted an Award, and
the grant of an Award shall not be construed as giving a Participant the right to continued employment or any other relationship with the Company. The Company expressly reserves the right at any time to dismiss or otherwise terminate its
relationship with a Participant free from any liability or claim under the Plan, except as expressly provided in the applicable Award. 

(b)    No Rights As Stockholder. Subject to the provisions of the applicable Award, no Participant or Designated
Beneficiary shall have any rights as a stockholder with respect to any shares of Common Stock to be distributed with respect to an Award until becoming the record holder of such shares. 

(c)    Effective Date and Term of Plan. The Company’s 2011 Stock Incentive Plan was originally effective on
            , 2011. This Amended and Restated 2011 Stock Incentive Plan shall become effective on the date on which it is adopted by the Board. No Awards shall be granted under the Plan
after the expiration of 10 years from the earlier of (i) the date on which the Plan was adopted by the Board or (ii) the date the Plan was approved by the Company’s stockholders, but Awards previously granted may extend beyond that
date. 
 (d)    Amendment of Plan. The Board may amend, suspend or terminate the Plan or any portion thereof at
any time; provided that if at any time the approval of the Company’s stockholders is required as to any modification or amendment under Section 422 of the Code or any successor provision with respect to Incentive Stock Options, the Board
may not effect such modification or amendment without such approval. Unless otherwise specified in the amendment, any amendment to the Plan adopted in accordance with this Section 10(d) shall apply to, and be binding on the holders of, all
Awards outstanding under the Plan at the time the amendment is adopted, provided the Board determines that such amendment does not materially and adversely affect the rights of Participants under the Plan. 

(e)    Authorization of Sub-Plans. The Board may from time to time
establish one or more sub-plans under the Plan for purposes of satisfying applicable blue sky, securities or tax laws of various jurisdictions. The Board shall establish such
sub-plans by adopting supplements to this Plan containing (i) such limitations on the Board’s discretion under the Plan as the Board deems necessary or desirable or (ii) such additional or
different terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants
within the affected jurisdiction and the Company shall not be required to provide copies of any supplement to Participants in any jurisdiction which is not the subject of such supplement. 

  
 10 

 (f)    Compliance with Code Section 409A. Awards are
intended to be exempt from Section 409A to the greatest extent possible and to otherwise comply with Section 409A. The Plan and all Awards shall be interpreted in accordance with such intent. To the extent that any Award is
determined to constitute “nonqualified deferred compensation” within the meaning of Section 409A (a “409A Award”), the Award shall be subject to such additional rules and requirements as specified by the Board from
time to time in order to comply with Section 409A. Further, the settlement of any 409A Award may not be accelerated except to the extent permitted by Section 409A. In this regard, if any amount under a 409A Award is payable
upon a “separation from service” (within the meaning of Section 409A) to a grantee who is considered a “specified employee” (within the meaning of Section 409A), then no such payment shall be made prior to
the date that is the earlier of (i) six months and one day after the grantee’s separation from service, or (ii) the grantee’s death, but only to the extent such delay is necessary to prevent such payment from being
subject to interest, penalties and/or additional tax imposed pursuant to Section 409A. The Company shall have no liability to a Participant, or any other party, if an Award that is intended to be exempt from, or compliant with,
Section 409A is not so exempt or compliant or for any action taken by the Board. 
 (g)    Governing
Law. The provisions of the Plan and all Awards made hereunder shall be governed by and interpreted in accordance with the laws of the State of Delaware, excluding
choice-of-law principles of the law of such state that would require the application of the laws of a jurisdiction other than such state. 

  
 11 

 

 
 Nonstatutory Stock Option Agreement 

Granted Under the Amended and Restated 2011 Stock Incentive Plan 

11.    Grant of Option. 

This agreement evidences the grant by Akili Interactive Labs, Inc., a Delaware corporation (the “Company”), on
                     (the “Grant Date”) to
                    , a consultant of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms
provided herein and in the Company’s Amended and Restated 2011 Stock Incentive Plan (the “Plan”), a total of              shares (the “Shares”) of common stock,
$0.0001 par value per share, of the Company (“Common Stock”) at $    .     per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [10 years from
Grant Date] (the “Final Exercise Date”). 
 It is intended that the option evidenced by this agreement shall not be an
incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term
“Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. 

12.    Vesting Schedule. 

[This option is fully vested.] 

[This option will become exercisable (“vest”) as to 25% of the original number of Shares on
                     (the “Vesting Commencement Date”) and as to 12.5% of the original number of Shares at the end of each successive
six-month period following the Vesting Commencement Date, provided the Participant remains in continuous service with the Company through each such vesting date. 

The right of exercise shall be cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it
shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option under Section 3 hereof or the Plan. 

  
 12 

 13.    Exercise of Option. 

(a)    Form of Exercise. Each election to exercise this option shall be in writing, signed by the Participant, and
received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan. The Participant may purchase less than the number of Shares covered hereby, provided that no partial exercise of
this option may be for any fractional share. 
 (b)    Continuous Relationship with the Company Required. Except
as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer or director of, or
consultant or advisor to, the Company or any other entity the employees, officers, directors, consultants, or advisors of which are eligible to receive option grants under the Plan (an “Eligible Participant”). 

(c)    Termination of Relationship with the Company. If the Participant ceases to be an Eligible Participant for
any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but in no event after the Final Exercise Date), provided that this
option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option
shall terminate immediately upon such violation. 
 (d)    Exercise Period Upon Death or Disability. If the
Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as
specified in paragraph (e) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee),
provided that this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after
the Final Exercise Date. 
 (e)    Termination for Cause. If, prior to the Final Exercise Date, the
Participant’s employment or other relationship with the Company is terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment
or other relationship. If the Participant is party to an employment, consulting or severance agreement with the Company that contains a definition of “cause” for termination of employment or other relationship, “Cause” shall have
the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean willful misconduct by the Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without
limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined
by the Company, which determination shall be conclusive. The Participant’s employment or other relationship shall be considered to have been terminated for “Cause” if the Company determines, within 30 days after the Participant’s
resignation, that termination for Cause was warranted. 

  
 13 

 14.    Company Right of First Refusal. 

(a)    Notice of Proposed Transfer. If the Participant proposes to sell, assign, transfer, pledge, hypothecate or
otherwise dispose of, by operation of law or otherwise (collectively, “transfer”) any Shares acquired upon exercise of this option, then the Participant shall first give written notice of the proposed transfer (the “Transfer
Notice”) to the Company. The Transfer Notice shall name the proposed transferee and state the number of such Shares the Participant proposes to transfer (the “Offered Shares”), the price per share and all other material terms and
conditions of the transfer. 
 (b)    Company Right to Purchase. For 30 days following its receipt of such
Transfer Notice, the Company shall have the option to purchase all or part of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all or part of the Offered Shares, it
shall give written notice of such election to the Participant within such 30-day period. Within 10 days after his or her receipt of such notice, the Participant shall tender to the Company at its principal
offices the certificate or certificates representing the Offered Shares to be purchased by the Company, duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto, all in a form suitable for transfer of the Offered
Shares to the Company. Promptly following receipt of such certificate or certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered Shares; provided that if the terms of
payment set forth in the Transfer Notice were other than cash against delivery, the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice; and provided further that any delay
in making such payment shall not invalidate the Company’s exercise of its option to purchase the Offered Shares. 

(c)    Shares Not Purchased By Company. If the Company does not elect to acquire all of the Offered Shares, the
Participant may, within the 30-day period following the expiration of the option granted to the Company under subsection (b) above, transfer the Offered Shares which the Company has not elected to acquire
to the proposed transferee, provided that such transfer shall not be on terms and conditions more favorable to the transferee than those contained in the Transfer Notice. Notwithstanding any of the above, all Offered Shares transferred
pursuant to this Section 4 shall remain subject to the right of first refusal set forth in this Section 4 and such transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such
transferee shall be bound by all of the terms and conditions of this Section 4. 
 (d)    Consequences of Non-Delivery. After the time at which the Offered Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any dividend to
the Participant on account of such Offered Shares or permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Offered Shares, but shall, insofar as permitted by law, treat the Company as the owner of
such Offered Shares. 

  
 14 

 (e)    Exempt Transactions. The following transactions shall be
exempt from the provisions of this Section 4: 
 (1)    any transfer of Shares to or for the benefit of any
spouse, child or grandchild of the Participant, or to a trust for their benefit; 
 (2)    any transfer pursuant to an
effective registration statement filed by the Company under the Securities Act of 1933, as amended (the “Securities Act”); and 

(3)    the sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant
to a merger or consolidation); 
 provided, however, that in the case of a transfer pursuant to clause (1) above, such Shares shall
remain subject to the right of first refusal set forth in this Section 4. 
 (f)    Assignment of Company
Right. The Company may assign its rights to purchase Offered Shares in any particular transaction under this Section 4 to one or more persons or entities. 

(g)    Termination. The provisions of this Section 4 shall terminate upon the earlier of the following events:

 (1)    the closing of the sale of shares of Common Stock in an underwritten public offering pursuant to an effective
registration statement filed by the Company under the Securities Act; or 
 (2)    the sale of all or substantially all
of the outstanding shares of capital stock, assets or business of the Company, by merger, consolidation, sale of assets or otherwise (other than a merger or consolidation in which all or substantially all of the individuals and entities who were
beneficial owners of the Company’s voting securities immediately prior to such transaction beneficially own, directly or indirectly, more than 50% (determined on an as-converted basis) of the outstanding
securities entitled to vote generally in the election of directors of the resulting, surviving or acquiring corporation in such transaction). 

(h)    No Obligation to Recognize Invalid Transfer. The Company shall not be required (1) to transfer on its
books any of the Shares which shall have been sold or transferred in violation of any of the provisions set forth in this Section 4, or (2) to treat as owner of such Shares or to pay dividends to any transferee to whom any such Shares
shall have been so sold or transferred. 
 (i)    Legends. The certificate representing Shares shall bear a
legend substantially in the following form (in addition to, or in combination with, any legend required by applicable federal and state securities laws and agreements relating to the transfer of the Company securities): 

“The shares represented by this certificate are subject to a right of first refusal in favor of the Company, as provided in a certain
stock option agreement with the Company.” 

  
 15 

 15.    Agreement in Connection with Initial Public Offering. 

The Participant agrees, in connection with the initial underwritten public offering of the Common Stock pursuant to a registration statement
under the Securities Act, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to
purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any other securities of the Company or (b) enter into any swap or other agreement that transfers, in whole or in part, any of the economic
consequences of ownership of shares of Common Stock or other securities of the Company, whether any transaction described in clause (a) or (b) is to be settled by delivery of securities, in cash or otherwise, during the period beginning on the
date of the filing of such registration statement with the Securities and Exchange Commission and ending 180 days after the date of the final prospectus relating to the offering (plus up to an additional 34 days to the extent requested by the
managing underwriters for such offering in order to address Rule 2711(f) of the National Association of Securities Dealers, Inc. or any similar successor provision), and (ii) to execute any agreement reflecting clause (i) above as may be
requested by the Company or the managing underwriters at the time of such offering. The Company may impose stop-transfer instructions with respect to the shares of Common Stock or other securities subject to the foregoing restriction until the end
of the “lock-up” period. 
 16.    Withholding. 

No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision
satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option. 

17.    Transfer Restrictions. 

(a)    This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either
voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

 (b)    The Participant agrees that he or she will not transfer any Shares issued pursuant to the exercise of this
option unless the transferee, as a condition to such transfer, delivers to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of Section 4 and Section 5; provided that such a
written confirmation shall not be required with respect to (1) Section 4 after such provision has terminated in accordance with Section 4(g) or (2) Section 5 after the completion of the
lock-up period in connection with the Company’s initial underwritten public offering. 

18.    Provisions of the Plan. 

This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is
furnished to the Participant with this option. 

  
 16 

 IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate
seal by its duly authorized officer. This option shall take effect as a sealed instrument. 
  

			
	AKILI INTERACTIVE LABS, INC.
		
	By:	 	  

	Name:	 	W. Eddie Martucci, Ph.D.
	Title:	 	Chief Executive Officer

  
 17 

 PARTICIPANT’S ACCEPTANCE 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges
receipt of a copy of the Company’s 2011 Stock Incentive Plan. 
  

			
	PARTICIPANT:
		
	Sign:	 	  

		 	[NAME]
		
	Address:	 	  

		
		 	  

  
 18 

 

 
 Incentive Stock Option Agreement 

Granted Under the Amended and Restated 2011 Stock Incentive Plan 

19.    Grant of Option. 

This agreement evidences the grant by Akili Interactive Labs, Inc., a Delaware corporation (the “Company”), on ______________ (the
“Grant Date”) to ___________________, an employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Amended and Restated Company’s 2011 Stock Incentive
Plan (the “Plan”), a total of _______________ shares (the “Shares”) of common stock, $0.0001 par value per share, of the Company (“Common Stock”) at $_.__ per Share. Unless earlier terminated, this option
shall expire at 5:00 p.m., Eastern time, on [10 years from Grant Date] (the “Final Exercise Date”). 
 It is
intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as
otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms. To the extent any portion of the option does
not so qualify, it shall be deemed a non-qualified stock option. 
 20.    Vesting
Schedule. 
 This option will become exercisable (“vest”) as to 25% of the original number of Shares on _______________ (the
“Vesting Commencement Date”) and as to 12.5% of the original number of Shares at the end of each successive six-month period following the Vesting Commencement Date, provided the
Participant remains in continuous service with the Company through each such vesting date. 
 The right of exercise shall be cumulative so
that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date
or the termination of this option under Section 3 hereof or the Plan. 
 21.    Exercise of Option. 

(a)    Form of Exercise. Each election to exercise this option shall be in writing, signed by the Participant, and
received by the Company at its principal office, accompanied by this 

  
 19 

 
agreement, and payment in full in the manner provided in the Plan. The Participant may purchase less than the number of Shares covered hereby, provided that no partial exercise of this option may
be for any fractional share. 
 (b)    Continuous Relationship with the Company Required. Except as otherwise
provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer or director of, or consultant or advisor to,
the Company or any parent or subsidiary of the Company as defined in Section 424(e) or (f) of the Code (an “Eligible Participant”). 

(c)    Termination of Relationship with the Company. If the Participant ceases to be an Eligible Participant for
any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but in no event after the Final Exercise Date), provided that this
option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option
shall terminate immediately upon such violation. 
 (d)    Exercise Period Upon Death or Disability. If the
Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as
specified in paragraph (e) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), provided
that this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final
Exercise Date. 
 (e)    Termination for Cause. If, prior to the Final Exercise Date, the Participant’s
employment is terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment. If the Participant is party to an employment or severance
agreement with the Company that contains a definition of “cause” for termination of employment, “Cause” shall have the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean willful misconduct by
the Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure,
non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant’s employment shall be considered to have been terminated for Cause if
the Company determines, within 30 days after the Participant’s resignation, that termination for Cause was warranted. 

  
 20 

 22.    Company Right of First Refusal. 

(a)    Notice of Proposed Transfer. If the Participant proposes to sell, assign, transfer, pledge, hypothecate or
otherwise dispose of, by operation of law or otherwise (collectively, “transfer”) any Shares acquired upon exercise of this option, then the Participant shall first give written notice of the proposed transfer (the “Transfer
Notice”) to the Company. The Transfer Notice shall name the proposed transferee and state the number of such Shares the Participant proposes to transfer (the “Offered Shares”), the price per share and all other material terms and
conditions of the transfer. 
 (b)    Company Right to Purchase. For 30 days following its receipt of such
Transfer Notice, the Company shall have the option to purchase all or part of the Offered Shares at the price and upon the terms set forth in the Transfer Notice. In the event the Company elects to purchase all or part of the Offered Shares, it
shall give written notice of such election to the Participant within such 30-day period. Within 10 days after his or her receipt of such notice, the Participant shall tender to the Company at its principal
offices the certificate or certificates representing the Offered Shares to be purchased by the Company, duly endorsed in blank by the Participant or with duly endorsed stock powers attached thereto, all in a form suitable for transfer of the Offered
Shares to the Company. Promptly following receipt of such certificate or certificates, the Company shall deliver or mail to the Participant a check in payment of the purchase price for such Offered Shares; provided that if the terms of
payment set forth in the Transfer Notice were other than cash against delivery, the Company may pay for the Offered Shares on the same terms and conditions as were set forth in the Transfer Notice; and provided further that any delay
in making such payment shall not invalidate the Company’s exercise of its option to purchase the Offered Shares. 

(c)    Shares Not Purchased By Company. If the Company does not elect to acquire all of the Offered Shares, the
Participant may, within the 30-day period following the expiration of the option granted to the Company under subsection (b) above, transfer the Offered Shares which the Company has not elected to acquire
to the proposed transferee, provided that such transfer shall not be on terms and conditions more favorable to the transferee than those contained in the Transfer Notice. Notwithstanding any of the above, all Offered Shares transferred
pursuant to this Section 4 shall remain subject to the right of first refusal set forth in this Section 4 and such transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such
transferee shall be bound by all of the terms and conditions of this Section 4. 
 (d)    Consequences of Non-Delivery. After the time at which the Offered Shares are required to be delivered to the Company for transfer to the Company pursuant to subsection (b) above, the Company shall not pay any dividend to
the Participant on account of such Offered Shares or permit the Participant to exercise any of the privileges or rights of a stockholder with respect to such Offered Shares, but shall, insofar as permitted by law, treat the Company as the owner of
such Offered Shares. 
 (e)    Exempt Transactions. The following transactions shall be exempt from the
provisions of this Section 4: 
 (1)    any transfer of Shares to or for the benefit of any spouse, child or
grandchild of the Participant, or to a trust for their benefit; 

  
 21 

 (2)    any transfer pursuant to an effective registration statement
filed by the Company under the Securities Act of 1933, as amended (the “Securities Act”); and 
 (3)    the
sale of all or substantially all of the outstanding shares of capital stock of the Company (including pursuant to a merger or consolidation); 

provided, however, that in the case of a transfer pursuant to clause (1) above, such Shares shall remain subject to the right of first
refusal set forth in this Section 4. 
 (f)    Assignment of Company Right. The Company may assign its
rights to purchase Offered Shares in any particular transaction under this Section 4 to one or more persons or entities. 

(g)    Termination. The provisions of this Section 4 shall terminate upon the earlier of the following events:

 (1)    the closing of the sale of shares of Common Stock in an underwritten public offering pursuant to an effective
registration statement filed by the Company under the Securities Act; or 
 (2)    the sale of all or substantially all
of the outstanding shares of capital stock, assets or business of the Company, by merger, consolidation, sale of assets or otherwise (other than a merger or consolidation in which all or substantially all of the individuals and entities who were
beneficial owners of the Company’s voting securities immediately prior to such transaction beneficially own, directly or indirectly, more than 50% (determined on an as-converted basis) of the outstanding
securities entitled to vote generally in the election of directors of the resulting, surviving or acquiring corporation in such transaction). 

(h)    No Obligation to Recognize Invalid Transfer. The Company shall not be required (1) to transfer on its
books any of the Shares which shall have been sold or transferred in violation of any of the provisions set forth in this Section 4, or (2) to treat as owner of such Shares or to pay dividends to any transferee to whom any such Shares
shall have been so sold or transferred. 
 (i)    Legends. The certificate representing Shares shall bear a
legend substantially in the following form (in addition to, or in combination with, any legend required by applicable federal and state securities laws and agreements relating to the transfer of the Company securities): 

“The shares represented by this certificate are subject to a right of first refusal in favor of the Company, as provided in a certain
stock option agreement with the Company.” 
 23.    Agreement in Connection with Initial Public Offering. 

The Participant agrees, in connection with the initial underwritten public offering of the Common Stock pursuant to a registration statement
under the Securities Act, (i) not to (a) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to
purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any other securities of the Company or (b) enter into any swap or other agreement that transfers, in whole or in part,

  
 22 

 
any of the economic consequences of ownership of shares of Common Stock or other securities of the Company, whether any transaction described in clause (a) or (b) is to be settled by
delivery of securities, in cash or otherwise, during the period beginning on the date of the filing of such registration statement with the Securities and Exchange Commission and ending 180 days after the date of the final prospectus relating to the
offering (plus up to an additional 34 days to the extent requested by the managing underwriters for such offering in order to address Rule 2711(f) of the National Association of Securities Dealers, Inc. or any similar successor provision), and
(ii) to execute any agreement reflecting clause (i) above as may be requested by the Company or the managing underwriters at the time of such offering. The Company may impose stop-transfer instructions with respect to the shares of Common
Stock or other securities subject to the foregoing restriction until the end of the “lock-up” period. 

24.    Tax Matters. 

(a)    Withholding. No Shares will be issued pursuant to the exercise of this option unless and until the
Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option. 

(b)    Disqualifying Disposition. The Participant understands that in order to obtain the benefits of an incentive
stock option under Section 422 of the Code, no sale or other disposition may be made of Shares for which incentive stock option treatment is desired within the one-year period beginning on the day after
the day of the transfer of such Shares to him or her, nor within the two-year period beginning on the day after the Grant Date and further that this option must be exercised within three months after
termination of employment as an employee (or 12 months in the case of death or disability to qualify as an incentive stock option). If the Participant disposes of Shares acquired upon exercise of this option within either of these periods, the
Participant shall notify the Company in writing within 30 days after such disposition. 
 25.    Transfer Restrictions. 

(a)    This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either
voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

 (b)    The Participant agrees that he or she will not transfer any Shares issued pursuant to the exercise of this
option unless the transferee, as a condition to such transfer, delivers to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of Section 4 and Section 5; provided that such a
written confirmation shall not be required with respect to (1) Section 4 after such provision has terminated in accordance with Section 4(g) or (2) Section 5 after the completion of the
lock-up period in connection with the Company’s initial underwritten public offering. 

26.    Provisions of the Plan. 

This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is
furnished to the Participant with this option. 

  
 23 

 IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate
seal by its duly authorized officer. This option shall take effect as a sealed instrument. 
  

			
	AKILI INTERACTIVE LABS, INC.
		
	By:	 	  

	Name:	 	W. Edward Martucci, Ph.D.
	Title:	 	Chief Executive Officer

  
 24 

 PARTICIPANT’S ACCEPTANCE 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges
receipt of a copy of the Company’s 2011 Stock Incentive Plan. 
  

			
	PARTICIPANT:
		
	Sign:	 	  

		 	[NAME]

 
			
		
	Address:	 	  

		 	  

  
 25Exhibit 10.1

    

     

    
       

      

      February 11, 2022

       

      John Stark

      

      

      Re:          Separation

          Agreement

      

      

      Dear John:

      

      

      The purpose of this letter agreement (this “Agreement”) is to
        confirm your resignation from Quantum-Si Incorporated (the “Company”) as its Chief Executive Officer as of February 8, 2022, and to set forth the terms of your resignation and separation from Company.  Payment of the Separation Benefits described
        below is contingent on your agreement to and compliance with the terms of this Agreement.  This Agreement shall become effective on the Effective Date (as defined below).

      

      

      	1.	
              Separation of Employment.  You resigned your employment
                with Company effective as of February 8, 2022 (the “Separation Date”).  You acknowledge and agree that from and after the Separation Date, you will
                not represent yourself as an employee or agent of Company.  As of the Separation Date, you also resigned as a director on Company’s Board of Directors (the “Board”) and from each and every office, position or responsibility in which you
                served for Company and each of its affiliates, subsidiaries or divisions.

            

      

      

      	2.	
              Company Equity. You were granted restricted stock units
                (“RSUs”) pursuant to the terms of the following agreements:

            

      

      

      	

            	•	
              Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement, dated as of February 17, 2021 (the “Time Vested Award”); and

            

      	

            	•	
              Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement, dated as of February 17, 2021 (the “Performance Vested Award”).

            

      

      

      Each of the forgoing RSUs is subject to the terms of Company’s 2013 Employee, Director and Consultant Equity Incentive Plan (the “Plan”).  Subject to Section 4, as of the Separation Date, you acknowledge and agree that the table below sets forth a complete and accurate list of RSUs as of
        the Separation Date:

      

      

      	
              Issuing Company

            	
              Grant Date

            	
              # of Shares 

              Granted

            	
              # of 

              Shares 

                Vested

            	
              Type of RSU

            
	 	
              Quantum-Si Incorporated

            	 	
              2/17/2021

            	
              1,703,460

            	
              425,866

            	
              Time Vested

            
	 	
              Quantum-Si Incorporated

            	 	
              2/17/2021

            	
              453,777

            	
              0

            	
              Performance Vested

            

      

      

      You acknowledge and agree that as of the Separation Date, you are not vested in 1,277,594 of the RSUs subject to the Time Vested Award
        and that you are not vested in 453,777 RSUs subject to the Performance Vested Award and that you forfeited all of the foregoing unvested RSUs as of the Separation Date.

      

      

      
        
          

      

      
      	3.	
              Separation Benefits.  In exchange for the promises and
                release of claims contained herein, Company shall provide you with the following (the “Separation Benefits”):

            

      

      

      	

            	(a)	
              A cash severance amount equal to $500,000.00 (the “Severance”), such amount
                representing one (1) year of your base salary. The Severance, less applicable withholdings, will be paid in a lump sum payment on the Company’s first payroll date occurring on or after the Effective Date.

            

      

      

      	

            	(b)	
              Notwithstanding the terms of the offer letter from Company dated October 28, 2020 (the “Offer

                    Letter”), Company will also pay you an amount equal to $352,750, such amount representing the bonus payable for the 2021 performance year (the “2021

                    Bonus”).  The 2021 Bonus, less all applicable withholdings, will be paid in a lump sum payment on Company’s first payroll date occurring on or after the Effective Date.

            

      

      

      	

            	(c)	
              The Company will pay you an additional amount equal to $250,000, such amount representing an additional special bonus payment (the “Special Bonus”).  The Special Bonus, less all applicable withholdings, will be paid to you in a lump sum on the first payroll date occurring on or after the Effective Date.

            

      

      

      	4.	
              COBRA Benefits.  Regardless of whether you sign the
                Agreement, you shall have the right to elect to continue your medical and dental benefits pursuant to the terms and conditions of COBRA. Your eligibility for benefits under COBRA, the amount of such benefits, and the terms and conditions of
                such benefits, shall be determined by COBRA statutory and regulatory guidelines.  Subject to your timely election of continuation coverage under COBRA and your signing this Agreement, Company will reimburse you or pay on your behalf the
                monthly premium payable to continue your and your eligible dependents’ participation in Company’s group health plan for the lesser of the period ending February 28, 2023 and the month in which you become eligible to participate in a
                subsequent employer’s group health benefits (the “COBRA Benefit”).  You will notify Company’s Human Resources Department in writing promptly
                following the date you accept employment with a subsequent employer.  If the reimbursement of any COBRA premiums would violate the nondiscrimination rules or cause the reimbursement of claims to be taxable under the Patient Protection and
                Affordable Care Act of 2010, together with the Health Care and Education Reconciliation Act of 2010 (collectively, the “Act”) or Section 105(h) of
                the Internal Revenue Code of 1986 (as amended) (the “Code”), Company-paid premiums will be treated as taxable payments and be subject to imputed
                income tax treatment to the extent necessary to eliminate any discriminatory treatment or taxation under the Act or Section 105(h) of the Code.

            

      

      

      	5.	
              No Other Compensation Due.  You acknowledge that except
                for the Severance, the 2021 Bonus, the Special Bonus and the COBRA Benefit (collectively, the “Separation Benefits”) and your final wages, including accrued, unpaid vacation time (which final wages will be paid to you in accordance with Company’s regular payroll practices and applicable
                law), you are not now and shall not in the future be entitled to any other compensation from Company or any of its affiliates, subsidiaries or divisions, without limitation, other wages, commissions, bonuses, vacation pay, holiday pay,
                equity, units, stock, stock options, carve out, paid time off or any other form of compensation or benefit.

            

      

      

      	6.	
              Unemployment Benefits.   By virtue of your separation of employment, you shall be entitled to apply for unemployment benefits. The determination of your eligibility for such benefits (and
                the amount of benefits to which you may be entitled) shall be made by the appropriate state agency pursuant to applicable state law.  Company agrees that it shall not contest any claim for unemployment benefits by you.  Company, of course,
                shall not be required to falsify any information.

            

      

      

      
        2

        
          

      

      	7.	
              Return of Property, Confidentiality, Non-Disparagement, and Related
                    Matters.  You expressly acknowledge and agree to the following:

            

      

      

      	

            	(a)	
              You have returned to Company all documents (and any copies, duplicates, or replicas thereof), and property, including, without limitation, any laptop computer that
                was provided to you by Company, any of its subsidiaries, and their respective divisions, affiliates, parents, subsidiaries and related entities (collectively, the “Company

                    Affiliates”) during your employment with Company, and that you will abide by any and all common law and/or statutory obligations relating to protection and non-disclosure of Company’s and Company Affiliates’ trade secrets
                and/or confidential and proprietary documents and information.

            

      

      

      	

            	(b)	
              In the event that you receive an order, subpoena, request, or demand for disclosure of Company’s or a Company Affiliate’s trade secrets and/or confidential and
                proprietary documents and information from any court or governmental agency, or from a party to any litigation or administrative proceeding, unless prohibited by a court or government agency order, you shall as soon as reasonably possible
                and prior to disclosure notify Company of the same, in order to provide Company with the opportunity to assert its or a Company Affiliate’s respective interests in addressing or opposing such order, subpoena, request, or demand.

            

      

      

      	

            	(c)	
              You agree that all information relating in any way to this Agreement, including the terms and amount of financial consideration provided for in this Agreement, shall
                be held confidential by you and shall not be publicized or disclosed to any person (other than an immediate family member, legal counsel or financial advisor, provided that any such individual to whom disclosure is made agrees to be bound
                by these confidentiality obligations), business entity or government agency (except as mandated by state or federal law).

            

      

      

      	

            	(d)	
              You previously executed a Non-Competition, Confidentiality and Intellectual Property Agreement dated October 28, 2020 (the “Confidentiality Agreement”).  The Confidentiality Agreement remains in full force and effect and survives the termination of your employment with Company.  You will honor and abide by the
                terms and provisions of the Confidentiality Agreement.

            

      

      

      	

            	(e)	
              You will not make any statements that are disparaging about, or adverse to, the interests or business of Company, any Company Affiliate and their respective officers,
                directors, employees, and direct or indirect controlling shareholders) including, without limitation, any statements that disparage any person, product, service, finances, financial condition, capability or any other aspect of the business
                of Company or any Company Affiliate (including its officers, directors, employees, and direct or indirect shareholders).  “Disparaging” statements are those that, directly or indirectly, impugn the character, honesty, integrity or morality
                or business acumen or abilities in connection with any aspect of the operation of business of the individual or entity being disparaged.  The Company agrees that it will cause the current members of the Company’s Board of Directors to not
                make any statements that are disparaging about, or adverse to, the interests of, you.  Notwithstanding the foregoing, this Section does not prohibit you, the Company or the members of the Company’s Board of Directors from cooperating or
                testifying truthfully in any internal Company or government inquiry or in which you are required to testify pursuant to subpoena or other valid legal process.

            

      

      

      
        3

        
          

      

      	

            	(f)	
              Your breach of any of the foregoing covenants by you shall constitute a material breach of this Agreement and shall relieve Company of any further obligations
                hereunder and, in addition to any other legal or equitable remedy available to Company, shall entitle Company to recover any Separation Benefits already paid or provided to you pursuant to Sections 3 and 4 of this Agreement.

            

      

      

      	8.	
              Your Release of Claims.

            

       

      	

            	(a)	
              You hereby agree and acknowledge that by signing this Agreement and accepting the Separation Benefits, and for other good and valuable consideration provided for in
                this Agreement, you are waiving and releasing your right to assert any form of legal claim against Company, any of Company Affiliates, their respective successors, predecessors and assigns and each of their respective owners, shareholders,
                partners, directors, officers, employees, trustees, agents, successors and assigns (the “Company Parties”) whatsoever for any alleged action,
                inaction or circumstance existing or arising from the beginning of time through the Effective Date.  Your waiver and release herein is intended to bar any form of legal claim, charge, complaint or any other form of action (jointly referred
                to as “Claims”) against Company or any of Company Parties seeking any form of relief including, without limitation, equitable relief (whether
                declaratory, injunctive or otherwise), the recovery of any damages or any other form of monetary recovery whatsoever (including, without limitation, back pay, front pay, compensatory damages, emotional distress damages, punitive damages,
                attorneys’ fees and any other costs) against Company or any Company Party, for any alleged action, inaction or circumstance existing or arising through the Effective Date. Without limiting the generality of the foregoing, you specifically waive and release Company and Company Parties from any waivable Claim arising from or related to your employment relationship with Company
                  through the Effective Date including, without limitation:

            

       

      	

            	(i)	
              Claims under any Connecticut (or any other state) or federal
                  discrimination, fair employment practices, or other employment related statute, regulation or executive order (as amended through the Effective Date), including but not limited to the Age Discrimination in Employment Act and the
                Older Workers Benefit Protection Act (29 U.S.C. § 621 et seq.), the Civil Rights Acts of 1866 and 1871 and Title VII of the Civil Rights
                Act of 1964 and the Civil Rights Act of 1991 (42 U.S.C. § 2000e et seq.), the Equal Pay Act (29 U.S.C. § 201 et seq.), the Genetic Information Non-Discrimination Act (42
                  U.S.C. §2000ff et seq.), the Uniformed Services Employment and Reemployment Rights Act of 1994 (38 U.S.C. § 4301 et seq.), the
                Equal Pay Act (29 U.S.C. § 201 et seq.), the Lily Ledbetter Fair Pay Act, the Americans with Disabilities Act of 1990 (42 U.S.C. § 12101 et seq.), the Rehabilitation Act of 1973, the Connecticut Fair Employment Practices Act and the Connecticut Equal Pay for
                Equal Work statute.

            

       

      	

            	(ii)	
              Claims under any Connecticut (or any other state) or federal employment
                  related statute, regulation or executive order (as amended through the Effective Date) relating to wages, hours or any other terms and conditions of employment, including but not limited to the National Labor Relations Act (29 U.S.C. § 151 et seq.), the Family and Medical Leave Act (29 U.S.C. §2601 et seq.), the Employee Retirement Income Security Act of 1974 (29 U.S.C. § 1000 et seq.),
                COBRA (29 U.S.C. § 1161 et seq.), the Worker Adjustment and Retraining Notification Act (29 U.S.C. § 2101 et seq.), the Connecticut Paid Family Leave Act, and any
                similar Connecticut or other federal, state or local statute, and specifically including Claims related to salary, overtime, commissions, vacation
                  pay, holiday pay, sick leave pay, dismissal pay, bonus pay, severance pay, or retaliation.

            

      

      

      
        4

        
          

      

      	

            	(iii)	
              Claims under any Connecticut (or any other state) or federal common law
                  theory, including, without limitation, wrongful discharge, breach of express or implied contract, breach of the implied covenant of good faith and fair dealing, privacy violations, invasion of privacy, promissory estoppel, unjust
                enrichment, breach of a covenant of good faith and fair dealing, wrongful termination in violation of public policy, defamation, interference with contractual relations, intentional or negligent infliction of emotional distress, fraudulent
                inducement, misrepresentation, deceit, fraud or negligence, rehire or reemployment rights or any claim to attorneys’ fees under any applicable statute or common law theory of recovery.

            

       

      	

            	(iv)	
              Claims under any Connecticut (or any other state) or federal statute, regulation, or executive order (as amended through the Effective Date) relating
                to whistleblower protections, violation of public policy, or any other form of retaliation or wrongful termination, including but not limited to the Sarbanes-Oxley Act of 2002, the Connecticut Whistleblower Protection Act and any similar
                Connecticut or other federal, state or local statute.

            

       

      	

            	(v)	
              Claims under any Company employment, compensation, bonus, benefit, stock option, incentive compensation, restricted stock unit, and/or equity plan,
                program, policy, practice, or agreement, including, without limitation, any equity award or plan, or employment agreement, including the Offer Letter between you and Company dated as of October 28, 2020, and the Quantum-Si Incorporated
                Executive Severance Plan adopted as of June 29, 2021; or

            

       

      	

            	(vii)	
              Any other Claim arising under other local, state, or federal law.

            

       

      	

            	(b)	
              Notwithstanding the foregoing, this Section 8 does not:

            

      

      

      	

            	(i)	
              Release Company or any Company Party from any obligation expressly set forth in this Agreement;

            

      

      

      	

            	(ii)	
              Waive or release any legal claims to vested benefits under Company’s employee benefit plans, including Company’s 401(k) plan;

            

      

      

      	

            	(iii)	
              Waive or release any legal claims which you may not waive or release by law, including obligations under workers’ compensation laws;

            

      

      

      	

            	(iv)	
              Waive or release any legal claims to indemnification under the Indemnification Agreement dated as of June 10, 2021 (the “Indemnification Agreement”) between you and Company or under Company’s director and officers’ insurance policies in effect from time to time;

            

      

      

      
        5

        
          

      

      	

            	(v)	
              Prohibit you from (i) filing a charge with, or participating in or assisting with an investigation or proceeding conducted by, any governmental, regulatory and/or
                administrative entity or agency (including the Securities Exchange Commission, the Equal Employment Opportunity Commission, the Connecticut Commission on Human Rights and Opportunities, and/or OSHA); (ii) filing and, including as provided for under Section 21F of the
                Securities Exchange Act of 1934 (and Regulation 21F thereunder), maintaining the confidentiality of, a claim with a governmental, regulatory and/or administrative entity or agency that is responsible for enforcing a law; or (iii) providing
                truthful information to a governmental, regulatory and/or administrative entity or agency, law enforcement, or court, in response to compulsory legal process or as otherwise required by law or legal process or as permitted by Section 21F of
                the Securities Exchange Act of 1934 (or Regulation 21F thereunder); provided, however, you waive the right to recover any personal damages or other personal relief based on any claim, cause of action, demand, lawsuit or similar that is
                waived pursuant to this Agreement and brought by you or on your behalf by any third party, including as a member of any class or collective action, except that you do not waive any right to receive and fully retain any monetary award from a
                government-administered whistleblower award program for providing information to a government agency, including but not limited to damages or relief that may be available to you pursuant to such a program under the Securities Exchange Act
                of 1934.

            

      

      

      	

            	(c)	
              You further understand and expressly agree that this Agreement extends to all claims of every nature and kind, known or unknown, suspected or unsuspected, past or
                present, arising from or attributable to any conduct of Company or any Company Party. You acknowledge that you may later discover facts in addition to or different from those which you now believe to be true with respect to the matters
                released in this Agreement.  You, however, agree that you have taken that possibility into account in reaching this Agreement, and that the release in this Agreement will remain in effect as a full and complete release for all claims
                existing as of the date you execute this Agreement, notwithstanding the discovery or existence of additional or different facts.

            

      

      

      	

            	(d)	
              You acknowledge and agree that, but for providing this waiver and release, you would not be receiving the Separation Benefits provided to you under the terms of this
                Agreement.

            

      

      

      	9.	
              Waiver of Employment.  You hereby waive and release
                forever any right or rights you may have to employment with Company and any affiliate thereof at any time in the future, and agree not to seek or make application for employment with Company or any affiliate thereof.

            

      

      

      	10.	
              Reference Requests.  To the extent Company receives any
                reference request for you from a prospective employer, Company shall only provide dates of employment and last position held, and shall not otherwise characterize or discuss the nature of or circumstances surrounding your separation from
                employment from Company.

            

      

      

      	11.	
              Modification; Waiver; Severability.  No variations or
                modifications hereof shall be deemed valid unless reduced to writing and signed by the parties hereto. The failure of Company to seek enforcement of any provision of this Agreement in any instance or for any period of time shall not be
                construed as a waiver of such provision or of Company’s right to seek enforcement of such provision in the future.  The provisions of this Agreement are severable, and if for any reason any part hereof shall be found to be unenforceable,
                the remaining provisions shall be enforced in full.

            

      

      

      	12.	
              Choice of Law and Venue; Jury Waiver.   This Agreement
                shall be deemed to have been made in Connecticut and shall be governed by and construed in accordance with the laws of Connecticut, without giving effect to conflict of law principles.  Both parties hereby waive and renounce in advance any right to a trial by jury in connection with such legal action.

            

      

      

      
        6

        
          

      

      	13.	
              Entire Agreement. You acknowledge and agree that, other
                than the Confidentiality Agreement and the Indemnification Agreement, which are expressly incorporated herein by reference and stated as surviving the signing of this Agreement, this Agreement supersedes any and all prior or contemporaneous
                oral and written agreements between you and Company, and sets forth the entire agreement between you and Company.

            

      

      

      	14.	
              Tax Matters.  Company will withhold required federal,
                state, and local taxes from any and all payments contemplated by this Agreement.  Other than Company’s obligation and right to withhold, you will be responsible for any and all taxes, interest, and penalties that may be imposed with respect
                to the payments contemplated by this Agreement (including, but not limited to, those imposed under Section 409A of the Code). It is intended that payments and benefits made or provided to you under this Agreement shall comply with Section
                409A of the Code or an exemption to Section 409A of the Code.  You acknowledge and agree, however, that Company does not guarantee the tax treatment or tax consequences associated with any payment or benefit arising under this Agreement,
                including, without limitation, to consequences related to Section 409A of the Code.  For purposes of the limitations on nonqualified deferred compensation under Section 409A of the Code, each payment of compensation under this Agreement
                shall be treated as a separate payment of compensation for purposes of applying the exclusion under Section 409A of the Code for short-term deferral amounts, the separation pay exception or any other exception or exclusion under Section
                409A of the Code.

            

      

      

      	15.	
              Knowing and Voluntary Agreement. By executing this
                Agreement, you are acknowledging that you have been afforded sufficient time to understand the terms and effects of this Agreement, that your agreements and obligations hereunder are made voluntarily, knowingly and without duress, and that
                neither Company nor its agents or representatives have made any representations inconsistent with the provisions of this Agreement.

            

      

      

      	16.	
              ADEA Waiver.  You understand and agree that with
                respect to any possible claim arising under the Age Discrimination in Employment Act of 1967 (“ADEA”) you:

            

       

      	

            	(a)	
              Have had the opportunity to consider this Agreement for a full twenty-one (21) calendar days before executing it (the “Review Period”), and if signing this Agreement before the end of the Review Period, you have voluntarily waived the remainder of the Review Period.

            

       

      	

            	(b)	
              Have carefully read and fully understands all of the provisions of this Agreement.

            

       

      	

            	(c)	
              Are, through this Agreement, releasing Company and all of Company Parties from any and all claims you may have against them.

            

       

      	

            	(d)	
              Knowingly and voluntarily agree to all of the terms set forth in this Agreement.

            

       

      	

            	(e)	
              Knowingly and voluntarily intend to be legally bound by the terms of this Agreement.

            

       

      	

            	(f)	
              Were advised and hereby are advised in writing to consider the terms of this Agreement and to consult with an attorney of your choice prior to executing this
                Agreement.

            

       

      	

            	(g)	
              Understand that rights or claims under the ADEA that may arise due to acts or omissions that occur after the Effective Date are not waived.

            

       

      	

            	(h)	
              Understand that you have a period of seven (7) calendar days after the date that you sign this Agreement to revoke your acceptance of the terms of this Agreement by
                actually completing delivery of (not merely dispatching) a written notification by e-mail to Christian LaPointe, Ph.D., General Counsel, c/o Quantum-Si Incorporated, clapointe@quantum-si.com.

            

      

      

      
        7

        
          

      

      	17.	
              Execution and Delivery.  Delivery of this Agreement by
                you to Company shall be effective provided it is made no earlier than the Separation Date and no later than February 28, 2022.  The executed Agreement should be delivered to Company by scanning and then e-mailing it to Christian LaPointe,
                Ph.D., General Counsel, c/o Quantum-Si Incorporated, clapointe@quantum-si.com. You understand that you have seven (7) calendar days from the date you sign this Agreement to revoke your consent to this Agreement.  Any such revocation must be
                in writing and timely delivered by e-mail to the email address directly above.  If you revoke this Agreement, all of its provisions shall be void and unenforceable.  This Agreement shall become effective on the eighth day after you sign it,
                so long as you have not exercised your right to revoke it (such date, the “Effective Date”).

            

      

      

      [Signature Page Follows]

       

      

      
        8

        
          

      

      This Agreement may be signed on one or more copies, each of which when signed shall be deemed to be an original, and all of which together shall
        constitute one and the same Agreement.  If the foregoing correctly sets forth our understanding, please sign, date and return the enclosed copy of this Agreement in accordance with Section 16 above.

      

      

      Sincerely,

      

      

      QUANTUM-SI INCORPORATED

       

      

      
        	
                By:

              	
                /s/ Jonathan M. Rothberg

              
	 	
                Jonathan M. Rothberg

              
	 	
                Executive Chairman of the Board

              
	 	 
	Date: 

              	
                February 11, 2022

              

      

      
        

        

        Agreed and Acknowledged:

        

        

        
          	/s/ John Stark	 

                

          	
                  John Stark

                
	  
	Date:	February 11, 2022

        

        

        

        

        

        9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]